Envestnet Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.56M | Sell |
235,966
-7,282
| -3% | -$127K | ﹤0.01% | 2720 |
|
|
2026
Q1 | $4.66M | Buy |
243,248
+21,594
| +10% | +$469K | ﹤0.01% | 2360 |
|
|
2025
Q4 | $4.87M | Sell |
221,654
-14,678
| -6% | -$265K | ﹤0.01% | 2188 |
|
|
2025
Q3 | $2.87M | Sell |
236,332
-41,678
| -15% | -$564K | ﹤0.01% | 2638 |
|
|
2025
Q2 | $5.18M | Sell |
278,010
-40,520
| -13% | -$803K | ﹤0.01% | 2178 |
|
|
2025
Q1 | $6.1M | Buy |
318,530
+64,467
| +25% | +$1.89M | ﹤0.01% | 1983 |
|
|
2024
Q4 | $9.15M | Sell |
254,063
-11,606
| -4% | -$393K | ﹤0.01% | 1715 |
|
|
2024
Q3 | $11.3M | Buy |
265,669
+14,655
| +6% | +$621K | ﹤0.01% | 1552 |
|
|
2024
Q2 | $10.1M | Buy |
251,014
+19,004
| +8% | +$793K | ﹤0.01% | 1557 |
|
|
2024
Q1 | $8.22M | Buy |
232,010
+46,870
| +25% | +$1.26M | ﹤0.01% | 1653 |
|
|
2023
Q4 | $5.48M | Buy |
185,140
+166,907
| +915% | +$3.46M | ﹤0.01% | 1828 |
|
|
2023
Q3 | $379K | Buy |
18,233
+3,675
| +25% | +$101K | ﹤0.01% | 3395 |
|
|
2023
Q2 | $357K | Sell |
14,558
-7,111
| -33% | -$229K | ﹤0.01% | 3396 |
|
|
2023
Q1 | $880K | Sell |
21,669
-1,598
| -7% | -$66.2K | ﹤0.01% | 2763 |
|
|
2022
Q4 | $1.05M | Sell |
23,267
-5,735
| -20% | -$260K | ﹤0.01% | 2599 |
|
|
2022
Q3 | $1.39M | Buy |
29,002
+5,219
| +22% | +$286K | ﹤0.01% | 2310 |
|
|
2022
Q2 | $1.41M | Buy |
23,783
+6,722
| +39% | +$552K | ﹤0.01% | 2345 |
|
|
2022
Q1 | $1.98M | Buy |
17,061
+3,574
| +26% | +$417K | ﹤0.01% | 2196 |
|
|
2021
Q4 | $2.03M | Buy |
13,487
+636
| +5% | +$85.8K | ﹤0.01% | 2168 |
|
|
2021
Q3 | $1.53M | Buy |
12,851
+1,527
| +13% | +$168K | ﹤0.01% | 2269 |
|
|
2021
Q2 | $1.1M | Buy |
11,324
+323
| +3% | +$28.8K | ﹤0.01% | 2450 |
|
|
2021
Q1 | $971K | Buy |
11,001
+921
| +9% | +$85.6K | ﹤0.01% | 2422 |
|
|
2020
Q4 | $964K | Sell |
10,080
-1,444
| -13% | -$149K | ﹤0.01% | 2232 |
|
|
2020
Q3 | $1.31M | Buy |
11,524
+3,361
| +41% | +$353K | ﹤0.01% | 1859 |
|
|
2020
Q2 | $807K | Sell |
8,163
-4,335
| -35% | -$346K | ﹤0.01% | 2098 |
|
|
2020
Q1 | $804K | Buy |
12,498
+8,572
| +218% | +$601K | ﹤0.01% | 1945 |
|
|
2019
Q4 | $234K | Buy |
+3,926
| New | +$242K | ﹤0.01% | 2848 |
|
|
2019
Q2 | – | Sell |
-6,312
| Closed | -$401K | – | 3078 |
|
|
2019
Q1 | $401K | Buy |
+6,312
| New | +$332K | ﹤0.01% | 2470 |
|
|
2016
Q3 | – | Sell |
-165
| Closed | -$12K | – | 3058 |
|
|
2016
Q2 | $12K | Sell |
165
-890
| -84% | -$71.6K | ﹤0.01% | 3023 |
|
|
2016
Q1 | $92K | Buy |
1,055
+72
| +7% | +$6.3K | ﹤0.01% | 2441 |
|
|
2015
Q4 | $116K | Buy |
983
+224
| +30% | +$22.2K | ﹤0.01% | 2309 |
|
|
2015
Q3 | $67K | Buy |
+759
| New | +$88.4K | ﹤0.01% | 2520 |
|
Other funds holding TNDM
PIM
YIH
BS
MMA
BPC
FISPB
Envestnet Asset Management's TNDM Position: Q2 2026 in Review
Envestnet Asset Management reduced its Tandem Diabetes Care (TNDM) stake by 3% in Q2 2026, selling an estimated $127K and leaving 235,966 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2720.
Envestnet Asset Management first reported a position in TNDM in Q3 2015 and has held it in 32 quarters since. The position peaked at $11.3M in Q3 2024. 78 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Envestnet Asset Management held 235,966 shares of Tandem Diabetes Care worth $3.56M as of Q2 2026.
- Envestnet Asset Management sold 7,282 Tandem Diabetes Care shares in Q2 2026, an estimated $127K.
- Tandem Diabetes Care made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2720 holding.
- Envestnet Asset Management first reported a position in Tandem Diabetes Care in Q3 2015 and has held it in 32 quarters since.
- Envestnet Asset Management's Tandem Diabetes Care position peaked at $11.3M in Q3 2024.
- 78 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.